DK1812475T3 - Immunglobulinfraktioner - Google Patents
ImmunglobulinfraktionerInfo
- Publication number
- DK1812475T3 DK1812475T3 DK05807416.2T DK05807416T DK1812475T3 DK 1812475 T3 DK1812475 T3 DK 1812475T3 DK 05807416 T DK05807416 T DK 05807416T DK 1812475 T3 DK1812475 T3 DK 1812475T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunoglobulin fractions
- immunoglobulin
- fractions
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04025936A EP1652859A1 (en) | 2004-11-02 | 2004-11-02 | Immunoglobulin fractions |
| PCT/EP2005/011494 WO2006048174A2 (en) | 2004-11-02 | 2005-10-27 | Immunoglobulin fractions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1812475T3 true DK1812475T3 (da) | 2014-02-03 |
Family
ID=34927193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05807416.2T DK1812475T3 (da) | 2004-11-02 | 2005-10-27 | Immunglobulinfraktioner |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7887797B2 (da) |
| EP (3) | EP1652859A1 (da) |
| JP (1) | JP2008518887A (da) |
| KR (1) | KR20070085689A (da) |
| AU (1) | AU2005300753A1 (da) |
| CA (1) | CA2586067A1 (da) |
| DK (1) | DK1812475T3 (da) |
| ES (1) | ES2442457T3 (da) |
| WO (1) | WO2006048174A2 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010248938B2 (en) * | 2009-05-13 | 2014-12-11 | Gliknik Inc. | Methods of using immunoglobulin aggregates |
| CN102043051B (zh) * | 2009-10-15 | 2013-11-20 | 中国辐射防护研究院 | 一种筛选不同亚型单克隆抗体的方法 |
| US9107906B1 (en) * | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6090380A (en) * | 1994-01-12 | 2000-07-18 | Research Corporation Technologies, Inc. | Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin |
| AU5605398A (en) | 1996-12-11 | 1998-07-03 | University Of Florida | Novel methods and compositions for treatment of autoimmune diseases |
| US20040101909A1 (en) * | 2002-08-20 | 2004-05-27 | Hema-Quebec, 2535 Boul. Laurier, Ste-Foy, Quebec, Canada G1V 4M3 | Purification of polyreactive autoantibodies and uses thereof |
-
2004
- 2004-11-02 EP EP04025936A patent/EP1652859A1/en not_active Withdrawn
-
2005
- 2005-10-27 AU AU2005300753A patent/AU2005300753A1/en not_active Abandoned
- 2005-10-27 US US11/666,690 patent/US7887797B2/en active Active
- 2005-10-27 KR KR1020077012522A patent/KR20070085689A/ko not_active Withdrawn
- 2005-10-27 CA CA002586067A patent/CA2586067A1/en not_active Abandoned
- 2005-10-27 DK DK05807416.2T patent/DK1812475T3/da active
- 2005-10-27 JP JP2007538332A patent/JP2008518887A/ja not_active Abandoned
- 2005-10-27 WO PCT/EP2005/011494 patent/WO2006048174A2/en not_active Ceased
- 2005-10-27 ES ES05807416.2T patent/ES2442457T3/es not_active Expired - Lifetime
- 2005-10-27 EP EP05807416.2A patent/EP1812475B1/en not_active Expired - Lifetime
- 2005-10-27 EP EP09002383A patent/EP2062915A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2062915A3 (en) | 2009-07-22 |
| EP1652859A1 (en) | 2006-05-03 |
| JP2008518887A (ja) | 2008-06-05 |
| WO2006048174A8 (en) | 2007-09-20 |
| EP1812475A2 (en) | 2007-08-01 |
| EP1812475B1 (en) | 2013-10-23 |
| ES2442457T3 (es) | 2014-02-11 |
| AU2005300753A1 (en) | 2006-05-11 |
| KR20070085689A (ko) | 2007-08-27 |
| US7887797B2 (en) | 2011-02-15 |
| EP2062915A2 (en) | 2009-05-27 |
| US20090028846A1 (en) | 2009-01-29 |
| WO2006048174A2 (en) | 2006-05-11 |
| CA2586067A1 (en) | 2006-05-11 |
| WO2006048174A3 (en) | 2007-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2019034I1 (el) | 4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια | |
| NO20071430L (no) | Anti-OX4OL antistoffer | |
| MA28726B1 (fr) | Immunoglobulines | |
| MA28541B1 (fr) | Immunoglobulines | |
| NO20076607L (no) | TWEAK - bindende antistoff | |
| HRP20150176T1 (xx) | Protutijela protiv miostatina | |
| DK1964852T3 (da) | Anti-ilt7-antistof | |
| DE602006017373D1 (de) | Madcam-antikörper | |
| PL2177537T3 (pl) | Przeciwciała przeciw MadCAM | |
| DK1599504T3 (da) | Modificeret antistof | |
| DK1809978T3 (da) | Modul-skydebane | |
| EP1824784A4 (en) | MOLECULAR SIEVE HAVING HIGH SILICITY WITH CHA STRUCTURE | |
| DE112005001624A5 (de) | Brillengestell | |
| ATE520680T1 (de) | Hiv-hemmende 5-heterocyclylpyrimidine | |
| DE502005003777D1 (de) | Thiazolyl-dihydro-indazole | |
| ATE459633T1 (de) | Makrolide | |
| DE112005000809A5 (de) | Wankstabilisierungseinrichtung | |
| DE502004012213D1 (de) | Flachdichtung | |
| BRPI0509495A2 (pt) | anticorpo humanizado | |
| DE202004017327U1 (de) | Fitnessrad | |
| SE0400476L (sv) | Komponent | |
| DE502005002602D1 (de) | Fahrzeugtemperiersystem | |
| DK1812475T3 (da) | Immunglobulinfraktioner | |
| AT500198B1 (de) | Ladewagen | |
| DE112005000794T5 (de) | Urethanspritzpistolenanordnung |